IRSB - Iris BioTechnologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201512/31/201412/31/201312/31/2012
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development192.413199.66259.419130.19
Selling General and Administrative859.613987.878416.973440.146
Non Recurring----
Others----
Total Operating Expenses1,058.1061,190.304481.15584.328
Operating Income or Loss-1,058.106-1,190.304-481.15-584.328
Income from Continuing Operations
Total Other Income/Expenses Net-114.977-1.714-4.385-1.622
Earnings Before Interest and Taxes-1,058.106-1,190.304-481.15-584.328
Interest Expense-2.058-1.714-4.385-1.622
Income Before Tax-1,173.083-1,192.018-485.535-585.95
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-1,173.083-1,192.018-485.535-585.95
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-1,173.083-1,192.018-485.535-585.95
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-1,173.083-1,192.018-485.535-585.95